文献速递外周动脉疾病

旋转式斑块旋切辅助血管腔内治疗严重外周动脉疾病的中期结果

Midterm outcomes of rotational atherectomy-assisted endovascular treatment of severe peripheral arterial disease.
PubMed 文献 · J Vasc Surg · 2023-12-19

单中心回顾性分析103例Rutherford II至V级股腘动脉病变患者,采用Jetstream旋转式斑块旋切联合药物涂层球囊治疗,中位随访18.0±10.8个月,12个月和24个月一期通畅率分别为97%和83%,二期通畅率分别为99%和91%,技术成功率96.1%,辅助支架置入率9.8%。

要点

  • 旋转式斑块旋切联合药物涂层球囊治疗严重股腘动脉病变技术成功率96.1%,辅助支架置入率9.8%。
  • 中位随访18.0±10.8个月,12个月和24个月一期通畅率分别为97%和83%。
  • 病变位置、糖尿病状态和术者经验亚组间通畅率无显著差异。

核心结论

  • 旋转式斑块旋切联合药物涂层球囊治疗严重股腘动脉病变显示辅助支架置入需求相对较低,中期一期通畅率良好。
  • 病变位置、糖尿病或术者经验对通畅率的影响未显示统计学差异。
  • 需要更长期结果和对比分析以巩固进一步临床证据。

研究设计与样本

  • 单中心、医生发起、非企业资助的回顾性分析,纳入Rutherford II至V级、股浅动脉和/或腘动脉原发闭塞或狭窄病变患者,接受Jetstream旋转式斑块旋切联合药物涂层球囊治疗,共103例。
  • 排除标准包括:内膜下再通或无股浅动脉支架者、既往同侧旁路手术、全身性凝血病、需血液透析的终末期肾病、预期寿命<12个月、不耐受阿司匹林、氯吡格雷和/或肝素。

主要发现

  • 共纳入103例患者,股浅动脉和/或腘动脉病变长度中位数80 mm(四分位距61.2 mm),闭塞性病变73处(70.9%),Fanelli钙化评分3和4级84处(81.5%)。
  • 技术成功率为96.1%(n=99),中位手术时间108分钟,辅助支架置入10例(9.8%)。
  • 中位随访18.0±10.8个月,Rutherford分级临床改善77例(74.8%),靶病变闭塞需再干预7例(6.79%),其中6例(5.82%)接受再干预。
  • 12个月和24个月一期通畅率分别为97%和83%,二期通畅率分别为99%和91%。
  • 治疗不同位置病变、糖尿病与非糖尿病患者、经验丰富与无经验术者之间无显著差异。

局限性

  • 需要更长期结果和对比分析以巩固进一步临床证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We evaluated the midterm results of atherectomy-assisted angioplasty for the treatment of femoropopliteal lesions and the identification of possible subgroups of patients with superior outcomes. METHODS: We conducted a single-center, physician-initiated, nonindustry-sponsored retrospective analysis of patients with Rutherford category ranging from II to V and de novo occlusive or stenotic lesions of the superficial femoral (SFA) and/or popliteal arteries treated with atherectomy-assisted angioplasty (Jetstream rotational atherectomy + drug-eluting ballooning). In cases of subintimal recanalization or patients without an SFA stamp, with previous ipsilateral bypass surgery, systemic coagulopathy, end-stage renal disease requiring hemodialysis, life expectancy of <12 months, and intolerance to aspirin, clopidogrel, and/or heparin were excluded. RESULTS: In a total of 103 enrolled patients, the median SFA and/or popliteal lesion length was 80 mm (interquartile range, 61.2 mm) with 73 lesions being occlusive (70.9%) and 84 (81.5%) classified as Fanelli calcification score 3 and 4. Technical success was met in 96.1% of cases (n = 99) at a median operative time of 108 minutes. Adjunctive stenting was needed in 10 patients (9.8%). At a median follow-up of 18.0 ± 10.8 months, Rutherford class clinical improvement was present in 77 patients (74.8%), and 7 patients (6.79%) presented target lesion occlusion needing reintervention in 6 cases (5.82%). The primary patency rates were 97% at 12 months and 83% at 24 months with secondary patency rates of 99% at 12 months and 91% at 24 months of follow-up. There were no significant differences when treating differently located lesions, diabetic vs nondiabetic patients, or comparing experienced vs nonexperienced operators. CONCLUSIONS: The use of rotational atherectomy and drug-eluting balloons for the treatment of severe femoropopliteal disease showed relatively low need for bailout stenting and good midterm primary patency rates. The influence of lesion location, diabetes mellitus, or operator experience did not show statistically different results in terms of patency. Longer term outcomes and comparative analysis are needed to consolidate further clinical evidence.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Taneva GT, Pitoulias AG, Avranas K, et al. Midterm outcomes of rotational atherectomy-assisted endovascular treatment of severe peripheral arterial disease. J Vasc Surg. 2023. PMID: 38128846. doi:10.1016/j.jvs.2023.12.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。